inhibitors

On the Horizon – Many More Novel Drugs for the Treatment of Advanced Prostate Cancer

There have been many potential targets identified for the treatment of advanced prostate cancer. Many of these targets are being actively explored with clinical trials designed to test some inhibitors of the targets. Antisense oligonucleotides (OGX-011) targets clusterin, a chaperone protein and OGX-427 which targets heat-shock protein 27 are among the inhibitors being evaluated. OGX-011 [...]

By |2017-10-19T10:49:43-04:00June 27th, 2013|Advanced Prostate Cancer, Clinical Trials, Clinical Trials, Combination Therapy, Custirsen, Drugs & Treatments, General Information, On The Horizon, Tasquinimod (TASQ), Uncategorized, Understanding APC|0 Comments
Read More

From The AACR Meeting – Identifying New Drugs That Block Prostate Tumor Growth

Researchers from The Cancer Institute of New Jersey (CINJ) have identified candidate drugs that block a key protein responsible for tumor growth. Their research was presented at the recent Annual Meeting of the American Association for Cancer Research (AACR) which I had the good fortune to attend. As we know the common treatment for localized [...]

By |2010-04-28T11:43:04-04:00April 28th, 2010|Advanced Prostate Cancer, DOD, Metastases, On The Horizon, Uncategorized, Understanding APC|2 Comments
Read More
Go to Top